News in brief: Budesonide-formoterol for teens; Light smoking still a cancer risk; High rate of asthma admissions

More evidence supports GINA advice in teens As-needed budesonide-formoterol is a safe and viable treatment option in adolescent patients with mild asthma. A post hoc pooled analysis of the 889 adolescents in the SYGMA 1 and 2 trials found as-needed budesonide-formoterol was associated with a 77% reduction in the severe exacerbation rate compared to terbutaline, ...

Already a member?

Login to keep reading.

© 2021 the limbic